# TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial

> **NCT02031211** · NA · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- CRPS
- Chronic Regional Pain Syndrome

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02031211
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-06
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled.
- **Last updated:** 2016-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02031211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02031211, "TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02031211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*